Shifa Remedies Private Limited

Shifa Remedies Private Limited

Pharmaceutical and medical goods trading company with focus on citrasate and citrate dialysate.
2005 | Delhi (India) | Active

Last Updated:

October 24, 2024
HomeCompanyShifa Remedies Private Limited

Who are the key members and board of directors at Shifa Remedies?

Board Members(3)

NameDesignationAppointment DateStatus
Mohammad Tariq In Director 20-Apr-2005Current
Arif Khan In Director 20-Apr-2005Current
Asi Khan In Director 11-Feb-2008Current

Financial Performance of Shifa Remedies.

Shifa Remedies Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 45.08% increase. The company also saw a substantial fall in profitability, with a 28.04% decrease in profit. The company's net worth Soared by an impressive increase of 23.56%.

Revenue Growth Graph
Profit Loss Graph
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metric
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
45.08%
Revenue from Operations
42.21%
Total Assets
9.68%
Profit or Loss
-28.04%
Net Worth
23.56%
EBITDA
-46.63%

Related Corporates (Common Directorship)

Charges (Loans)

Open Charges

₹9.84 M

LenderAmountStatus

Others

Creation Date: 19 Dec 2023
₹0.60 MOpen

Hdfc Bank Limited

Creation Date: 25 Oct 2023
₹1.24 MOpen

Others

Creation Date: 06 Jan 2022
₹8.00 MOpen

How Many Employees Work at Shifa Remedies?

Unlock and access historical data on people associated with Shifa Remedies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Graph

Deals i

Rating

Alerts

Latest Updates, News, and FAQs on Shifa Remedies

Recent activity within the organization

  • Charges

    A charge with Others amounted to Rs. 0.60 M with Charge ID 100839788 was registered on 19 Dec 2023.

    19 Dec 2023

  • Charges

    A charge with Hdfc Bank Limited amounted to Rs. 1.24 M with Charge ID 100832869 was registered on 25 Oct 2023.

    25 Oct 2023

  • Annual General Meeting

    Shifa Remedies Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.

    30 Sep 2023

  • Balance Sheet

    Shifa Remedies Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Delhi.

    31 Mar 2023

  • Charges

    A charge with Others amounted to Rs. 8.00 M with Charge ID 100529646 was registered on 06 Jan 2022.

    06 Jan 2022

  • Director Appointment

    Asi Syeed Khan was appointed as a Director was appointed as a Director on 11 Feb 2008 & has been associated with this company since 16 years 10 months .

    11 Feb 2008

Frequently asked questions

  • Shifa Remedies Private Limited was incorporated on 20 Apr 2005.

  • The authorized share capital of Shifa Remedies Private Limited is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.

  • Currently 3 directors are associated with Shifa Remedies Private Limited.

    • Arif Sayeed Khan
    • Mohammad Tariq
    • Asi Syeed Khan
  • As per Ministry of Corporate Affairs (Mca), the registered address of Shifa Remedies Private Limited is B-21 First Floor Dda Shed Okhla Industrial Area, Phase-Ii India, New Delhi, 110020.

  • The corporate identification number (CIN) of Shifa Remedies Private Limited is U24232DL2005PTC135134 and the company number is 135134 as per Ministry of Corporate Affairs (MCA).

  • The Official website of Shifa Remedies Private Limited is https://www.shifaremedies.in

  • According to the financial reports for the fiscal year 2023, the revenue trend for Shifa Remedies Private Limited has risen by 45.08%.

  • The financial reports for the fiscal year 2023 indicates that The net worth of Shifa Remedies Private Limited has experienced an upsurge of 23.56%.

  • As per the financial statements for fiscal Year 2023, The total open charges for Shifa Remedies Private Limited amount to ₹ 9.84 M.

  • The most recent Balance Sheet for Shifa Remedies Private Limited was filed with the ROC on 31 Mar 2023.

People also Viewed

Similar Companies Based on Drug Formulation & Development